Home › Castration-Resistant Prostatic Cancer › New York
Pag-aaral pangklinika para sa Castration-Resistant Prostatic Cancer sa New York
8 pag-aaral para sa Castration-Resistant Prostatic Cancer ang naghahanap ng mga kalahok sa mga site sa New York.
Mga Lungsod sa New York
Opisyal na teksto ng pag-aaral (English)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
- NYU Langone Health Laura and Isaac Perlmutter Cancer Center, New York
- Montefiore Medical Center, The Bronx
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- NYU Langone Hospitals, Brooklyn
- NYU Langone Hospital Long Island, Mineola
- NYU Langone Health Laura and Isaac Perlmutter Cancer Center, New York
- at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 25, 2026 · NCT07164443A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Memorial Sloan Kettering Cancer Center ( Site 0006), New York
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06863272Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Northwell Health R.J. Zuckerberg Cancer Hospital, Lake Success
- NYU Langone Health Long Island, Mineola
- NYU Langone Health, New York
- at 3 pa
Nagre-recruitPhase 1
Edad 18 hanggang 100 · Kalalakihan · Na-update Ago 13, 2026 · NCT05519449A Study of MGC026 in Participants With Advanced Solid Tumors
- START-New York Long Island, Lake Success
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT06242470A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Ago 10, 2026 · NCT0606784164Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
- Weill Cornell Medicine at New York-Presbyterian, New York
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update May 6, 2026 · NCT04868604Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
- Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Nob 21, 2025 · NCT05743621Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.